StockData
ESMCOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends June 30

ESCALON MEDICAL CORP

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Oct 13, 2026
$0.18+0.01 (+7.65%)

Close on Oct 19, 2026

Market cap
$2.72M
P/E (TTM)
0.7
Dividend yield
–

About Escalon Medical

Electromedical & Electrotherapeutic Apparatus, SIC 3845

Escalon Medical Corp. develops, manufactures, markets, and distributes medical devices primarily for ophthalmic healthcare applications. The company's ophthalmic product portfolio features diagnostic ultrasound systems, including A-Scans for internal eye measurement, B-Scans for two-dimensional imaging of opaque ocular structures, high-resolution ultrasound biomicroscopy devices for anterior segment evaluation, and pachymeters for measuring corneal thickness. In addition to diagnostic equipment, it provides intraocular gases with delivery kits and disposable surgical packs for vitreoretinal procedures. The business also offers an image management platform that allows medical professionals to view and organize diagnostic images across multiple devices and locations. Escalon primarily markets and sells its products directly to medical institutions, vitreoretinal surgeons, and healthcare facilities worldwide.

The company operates internationally, distributing products across global markets and within the European Community through sales employees, independent representatives, and distributors. Operating facilities include leased manufacturing and service sites in New Berlin, Wisconsin, and Westbury, New York, employing 40 personnel. Escalon is organized under Pennsylvania law.

Summary of the business section of Escalon Medical's latest annual report, written by StockData.

Company profile

Company

Legal name
ESCALON MEDICAL CORP
Founded
1987
Headquarters
Wayne, PA
Address
435 Devon Park Road, Suite 824 19087
Phone
(610) 688-6830
Employees
40, Jun 30, 2026
Industry
Electromedical & Electrotherapeutic Apparatus
Incorporated in
Pennsylvania
Fiscal year ends
June 30
Auditor
CBIZ, CPAs P.C., Marlton, New Jersey

Stock & identifiers

Ticker
ESMC
Exchange
OTC
Shares outstanding
7M, May 14, 2026
Public float
$386.65K, Dec 31, 2024
Filer category
Non-accelerated filer<br>Smaller reporting company
Stock splits
1-for-4 reverse, Nov 24, 1997; 1-for-2.5 reverse, Nov 8, 1993
SEC CIK
862668
CUSIP
296074305
ISIN
US2960743050
EIN
33-0272839

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

No recent ownership filings by officers or directors

Escalon Medical's leadership is listed in its proxy statement (Form DEF 14A).

Employees

Headcount reported in annual reports

“As of June 30, 2026, the Company employed 40 employees.”

Corporate history

Events identified from SEC filings

DateEventDetails
Sep 28, 2026Late filingNotification of late filing
Jan 29, 2026Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Apr 4, 2025Auditor changeChange in certifying accountant (8-K Item 4.01)
Nov 15, 2023Late filingNotification of late filing
Sep 29, 2023Late filingNotification of late filing
Nov 2, 2022Auditor changeChange in certifying accountant (8-K Item 4.01)
Jan 24, 2018Auditor changeChange in certifying accountant (8-K Item 4.01)
Jan 25, 2017DelistingNotice of delisting from exchange (Form 25)
Nov 16, 2016Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Nov 15, 2016Late filingNotification of late filing
Sep 29, 2016Late filingNotification of late filing
Sep 6, 2016Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 22, 2016Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Mar 7, 2016Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Feb 23, 2016Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Dec 28, 2012Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Oct 10, 2012Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Aug 17, 2012Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Jun 29, 2012Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Feb 22, 2012Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Sep 29, 2010Late filingNotification of late filing
May 18, 2010Late filingNotification of late filing
May 6, 2010Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Feb 17, 2010Late filingNotification of late filing
Sep 29, 2009Late filingNotification of late filing
Jul 6, 2006Auditor changeChange in certifying accountant (8-K Item 4.01)
Jun 22, 2006Auditor changeChange in certifying accountant (8-K Item 4.01)
Sep 29, 2005Late filingNotification of late filing
Jan 6, 2005Auditor changeChange in certifying accountant (8-K Item 4.01)
Nov 16, 2004Late filingNotification of late filing